HIV-1 gp41 : Role in HIV Entry and Prevention

This publication has 54 references indexed in Scilit:

• Fusion-Competent Vaccines: Broad Neutralization of Primary Isolates of HIV
  Science, 1999
• A common epitope on gp41, IFN-α and IFN-β induces protective activity
  Immunology Today, 1998
• HIV Entry and Its Inhibition
  Published by Elsevier ,1998
• HIV-1 gp41 selectively inhibits spontaneous cell proliferation of human cell lines and mitogen- and recall antigen-induced lymphocyte proliferation
  Immunology Letters, 1995
• Two Partially Overlapping Antiviral Peptides from the External Portion of HIV Type 1 Glycoprotein 41, Adjoining the Transmembrane Region, Affect the Glycoprotein 41 Fusion Domain
  AIDS Research and Human Retroviruses, 1995
• A Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1
  AIDS Research and Human Retroviruses, 1994
• HIV-1 gp41 binds to several proteins on the human B-cell line, Raji
  Molecular Immunology, 1993
• Definition of Receptor Binding Domains in Interferon-α
  Journal of Interferon Research, 1992
• A synthetic peptide with sequence identity to the transmembrane protein GP41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx
  Cellular Immunology, 1991
• The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
  Nature, 1984